Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 302

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Randomized, Clinical Trial Comparison of Trisodium Citrate 30% and Heparin as Catheter-Locking Solution in Hemodialysis Patients

Weijmer, Marcel C., van den Dorpel, Marinus A., Van de Ven, Peter J.G., ter Wee, Pieter M., van Geelen, Jos A.C.A., Groeneveld, Johannes O., van Jaarsveld, Brigitte C., Koopmans, Marjon G., le Poole, Caatje Y., Schrander-Van der Meer, Anita M., Siegert, Carl E.H., Stas, Koen J.F. · 2005 · Journal of the American Society of Nephrology

Abstract

Interdialytic hemodialysis catheter-locking solutions could contribute to a reduction of catheter-related complications, especially infections. However, they can cause side effects because of leakage from the tip of the catheter. Recently, trisodium citrate (TSC) has been advocated because of its antimicrobial properties and local anticoagulation. In a multicenter, double-blind, randomized, controlled trial, TSC 30% was compared with unfractionated heparin 5000 U/ml for prevention of catheter-related infections, thrombosis, and bleeding complications. The study was stopped prematurely because of a difference in catheter-related bacteremia (CRB; P < 0.01). Of 363 eligible patients, 291 could be randomized. The study included 98 tunneled cuffed catheters and 193 untunneled. There were no significant differences in patient and catheter characteristics on inclusion. In the heparin group, 46% of catheters had to be removed because of any complication compared with 28% in the TSC group (P = 0.005). CRB rates were 1.1 per 1000 catheter-days for TSC versus 4.1 in the heparin group (P < 0.001). For tunneled cuffed catheters, the risk reduction for CRB was 87% (P < 0.001) and for untunneled catheters was 64% (P = 0.05). Fewer patients died from CRB in the TSC group (0 versus 5; P = 0.028). There were no differences in catheter flow problems and thrombosis (P = 0.75). No serious adverse events were encountered. Major bleeding episodes were significantly lower in the TSC group (P = 0.010). TSC 30% improves overall patency rates and reduces catheter-related infections and major bleeding episodes for both tunneled and untunneled hemodialysis catheters. Flow problems are not reduced.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1681/asn.2004100870

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Cited by

See all 302

Metadata

Authors
Weijmer, M. C., van den Dorpel, M. A., Van de Ven, P. J. G., ter Wee, P. M., van Geelen, J. A. C. A., Groeneveld, J. O., van Jaarsveld, B. C., Koopmans, M. G., le Poole, C. Y., Schrander-Van der Meer, A. M., Siegert, C. E. H., & Stas, K. J. F.
Venue
Journal of the American Society of Nephrology
Published
2005-09
Volume
16
Issue
9
Pages
2769-2777
ISSN
1046-6673 (ISSN-L)
OpenAlex
W2122847820
Cited by
302
References
21
FWCI
31.42
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Randomized, Clinical Trial Comparison of Trisodium Citrate 30% and Heparin as Catheter-Locking Solution in Hemodialysis Patients. https://app.cochat.ai/papers/10.1681/asn.2004100870
The paper
Weijmer, M. C., van den Dorpel, M. A., Van de Ven, P. J. G., ter Wee, P. M., van Geelen, J. A. C. A., Groeneveld, J. O., van Jaarsveld, B. C., Koopmans, M. G., le Poole, C. Y., Schrander-Van der Meer, A. M., Siegert, C. E. H., & Stas, K. J. F. (2005). Randomized, Clinical Trial Comparison of Trisodium Citrate 30% and Heparin as Catheter-Locking Solution in Hemodialysis Patients. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.2004100870

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.